APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Drug Delivery Systems

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

Selected research

Market Analysis & Forecast

Global Pulmonary Drug Delivery Systems Market Analysis and Forecast 2026-2032

2 January 2026204 pages

Choose your research edition.

Industry ResearchPulmonary Drug Delivery Systems Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Drug Delivery Systems Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Pulmonary Drug Delivery Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Drug Delivery Systems Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Drug Delivery Systems Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Pulmonary drug delivery systems are used to the treatment of various respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD), delivering locally acting drugs directly to their site of action. Advantages of pulmonary drug delivery systems over oral drugs is the excellent capability of absorbing pharmaceuticals, due to the large absorptive surface area of lungs (approximately 70-140 m2 in adult humans having extremely thin absorptive mucosal membrane) and good blood supply.

The major players in global Pulmonary Drug Delivery Systems market include 3M, GSK, AstraZeneca, etc. The top 3 players occupy about 60% shares of the global market. Europe and North America are main markets, they occupy over 75% of the global market. Metered Dose Inhaler (MDI) is the main type, with a share over 60%. COPD is the main application, which holds a share over 50%.

This report presents an overview of global market for Pulmonary Drug Delivery Systems, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Pulmonary Drug Delivery Systems, also provides the sales of main regions and countries. Of the upcoming market potential for Pulmonary Drug Delivery Systems, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pulmonary Drug Delivery Systems sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pulmonary Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pulmonary Drug Delivery Systems sales, projected growth trends, production technology, application and end-user industry.

Pulmonary Drug Delivery Systems Segment by Company

3M

GSK

AstraZeneca

Cipla

Chiesi

Boehringer Ingelheim

Aptar

Novartis

Philips Respironics

Omron Healthcare

PARI

Skyepharma

CareFusion

Shanghai Huarui

Taian Character

Chia Tai Tianqing

Pulmonary Drug Delivery Systems Segment by Type

Nebulizers

Dry Powder Inhaler (DPI)

Metered Dose Inhaler (MDI)

Pulmonary Drug Delivery Systems Segment by Application

COPD

Asthma

Others

Pulmonary Drug Delivery Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Drug Delivery Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Drug Delivery Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Drug Delivery Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pulmonary Drug Delivery Systems in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pulmonary Drug Delivery Systems manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Drug Delivery Systems sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nebulizers Major Manufacturers Table 3. Dry Powder Inhaler (DPI) Major Manufacturers Table 4. Metered Dose Inhaler (MDI) Major Manufacturers Table 5. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. COPD Major Manufacturers Table 7. Asthma Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pulmonary Drug Delivery Systems Industry Trends Table 10. Pulmonary Drug Delivery Systems Industry Drivers Table 11. Pulmonary Drug Delivery Systems Industry Opportunities and Challenges Table 12. Pulmonary Drug Delivery Systems Industry Restraints Table 13. Global Pulmonary Drug Delivery Systems Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pulmonary Drug Delivery Systems Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pulmonary Drug Delivery Systems Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2021-2026) Table 17. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2027-2032) Table 18. Global Pulmonary Drug Delivery Systems Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 19. Global Pulmonary Drug Delivery Systems Sales by Region (2021-2026) & (M Units) Table 20. Global Pulmonary Drug Delivery Systems Sales by Region (2027-2032) & (M Units) Table 21. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2021-2026) Table 22. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2027-2032) Table 23. Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pulmonary Drug Delivery Systems Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pulmonary Drug Delivery Systems Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Pulmonary Drug Delivery Systems Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pulmonary Drug Delivery Systems Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pulmonary Drug Delivery Systems Manufacturers, Product Type & Application Table 31. Global Pulmonary Drug Delivery Systems Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pulmonary Drug Delivery Systems by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pulmonary Drug Delivery Systems Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pulmonary Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2021-2026) Table 38. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2027-2032) Table 39. Global Pulmonary Drug Delivery Systems Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 40. Global Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units) Table 41. Global Pulmonary Drug Delivery Systems Sales by Type (2027-2032) & (M Units) Table 42. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2021-2026) Table 43. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2027-2032) Table 44. Global Pulmonary Drug Delivery Systems Price by Type (2021-2026) & (US$/Unit) Table 45. Global Pulmonary Drug Delivery Systems Price by Type (2027-2032) & (US$/Unit) Table 46. Global Pulmonary Drug Delivery Systems Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pulmonary Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2021-2026) Table 50. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2027-2032) Table 51. Global Pulmonary Drug Delivery Systems Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 52. Global Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units) Table 53. Global Pulmonary Drug Delivery Systems Sales by Application (2027-2032) & (M Units) Table 54. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2021-2026) Table 55. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2027-2032) Table 56. Global Pulmonary Drug Delivery Systems Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pulmonary Drug Delivery Systems Price by Application (2027-2032) & (US$/Unit) Table 58. 3M Company Information Table 59. 3M Business Overview Table 60. 3M Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. 3M Pulmonary Drug Delivery Systems Product Portfolio Table 62. 3M Recent Development Table 63. GSK Company Information Table 64. GSK Business Overview Table 65. GSK Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. GSK Pulmonary Drug Delivery Systems Product Portfolio Table 67. GSK Recent Development Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AstraZeneca Pulmonary Drug Delivery Systems Product Portfolio Table 72. AstraZeneca Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Cipla Pulmonary Drug Delivery Systems Product Portfolio Table 77. Cipla Recent Development Table 78. Chiesi Company Information Table 79. Chiesi Business Overview Table 80. Chiesi Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chiesi Pulmonary Drug Delivery Systems Product Portfolio Table 82. Chiesi Recent Development Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Portfolio Table 87. Boehringer Ingelheim Recent Development Table 88. Aptar Company Information Table 89. Aptar Business Overview Table 90. Aptar Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Aptar Pulmonary Drug Delivery Systems Product Portfolio Table 92. Aptar Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Novartis Pulmonary Drug Delivery Systems Product Portfolio Table 97. Novartis Recent Development Table 98. Philips Respironics Company Information Table 99. Philips Respironics Business Overview Table 100. Philips Respironics Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Philips Respironics Pulmonary Drug Delivery Systems Product Portfolio Table 102. Philips Respironics Recent Development Table 103. Omron Healthcare Company Information Table 104. Omron Healthcare Business Overview Table 105. Omron Healthcare Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Omron Healthcare Pulmonary Drug Delivery Systems Product Portfolio Table 107. Omron Healthcare Recent Development Table 108. PARI Company Information Table 109. PARI Business Overview Table 110. PARI Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. PARI Pulmonary Drug Delivery Systems Product Portfolio Table 112. PARI Recent Development Table 113. Skyepharma Company Information Table 114. Skyepharma Business Overview Table 115. Skyepharma Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Skyepharma Pulmonary Drug Delivery Systems Product Portfolio Table 117. Skyepharma Recent Development Table 118. CareFusion Company Information Table 119. CareFusion Business Overview Table 120. CareFusion Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. CareFusion Pulmonary Drug Delivery Systems Product Portfolio Table 122. CareFusion Recent Development Table 123. Shanghai Huarui Company Information Table 124. Shanghai Huarui Business Overview Table 125. Shanghai Huarui Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Shanghai Huarui Pulmonary Drug Delivery Systems Product Portfolio Table 127. Shanghai Huarui Recent Development Table 128. Taian Character Company Information Table 129. Taian Character Business Overview Table 130. Taian Character Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Taian Character Pulmonary Drug Delivery Systems Product Portfolio Table 132. Taian Character Recent Development Table 133. Chia Tai Tianqing Company Information Table 134. Chia Tai Tianqing Business Overview Table 135. Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Portfolio Table 137. Chia Tai Tianqing Recent Development Table 138. North America Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Pulmonary Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units) Table 141. North America Pulmonary Drug Delivery Systems Sales by Type (2027-2032) & (M Units) Table 142. North America Pulmonary Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 143. North America Pulmonary Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 144. North America Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Pulmonary Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units) Table 147. North America Pulmonary Drug Delivery Systems Sales by Application (2027-2032) & (M Units) Table 148. North America Pulmonary Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 149. North America Pulmonary Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 150. North America Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 154. North America Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units) Table 155. North America Pulmonary Drug Delivery Systems Sales by Country (2027-2032) & (M Units) Table 156. North America Pulmonary Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 157. North America Pulmonary Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 158. United States Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 159. Canada Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 160. Mexico Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 161. Europe Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Pulmonary Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units) Table 164. Europe Pulmonary Drug Delivery Systems Sales by Type (2027-2032) & (M Units) Table 165. Europe Pulmonary Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Europe Pulmonary Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Europe Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Pulmonary Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units) Table 170. Europe Pulmonary Drug Delivery Systems Sales by Application (2027-2032) & (M Units) Table 171. Europe Pulmonary Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Europe Pulmonary Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Europe Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 177. Europe Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units) Table 178. Europe Pulmonary Drug Delivery Systems Sales by Country (2027-2032) & (M Units) Table 179. Europe Pulmonary Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Europe Pulmonary Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Germany Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 182. France Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 183. U.K. Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 184. Italy Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 185. Russia Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 186. Spain Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 189. Sweden Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 190. Poland Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 191. China Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 192. China Pulmonary Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 193. China Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units) Table 194. China Pulmonary Drug Delivery Systems Sales by Type (2027-2032) & (M Units) Table 195. China Pulmonary Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 196. China Pulmonary Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 197. China Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 198. China Pulmonary Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 199. China Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units) Table 200. China Pulmonary Drug Delivery Systems Sales by Application (2027-2032) & (M Units) Table 201. China Pulmonary Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 202. China Pulmonary Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 203. Asia Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Pulmonary Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units) Table 206. Asia Pulmonary Drug Delivery Systems Sales by Type (2027-2032) & (M Units) Table 207. Asia Pulmonary Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 208. Asia Pulmonary Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 209. Asia Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Pulmonary Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units) Table 212. Asia Pulmonary Drug Delivery Systems Sales by Application (2027-2032) & (M Units) Table 213. Asia Pulmonary Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 214. Asia Pulmonary Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 215. Asia Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 219. Asia Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units) Table 220. Asia Pulmonary Drug Delivery Systems Sales by Country (2027-2032) & (M Units) Table 221. Asia Pulmonary Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 222. Asia Pulmonary Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 223. Japan Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 224. South Korea Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 225. India Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 226. Australia Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Pulmonary Drug Delivery Systems Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Pulmonary Drug Delivery Systems Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Pulmonary Drug Delivery Systems Sales by Type (2021-2026) & (M Units) Table 232. SAMEA Pulmonary Drug Delivery Systems Sales by Type (2027-2032) & (M Units) Table 233. SAMEA Pulmonary Drug Delivery Systems Sales Price by Type (2021-2026) & (US$/Unit) Table 234. SAMEA Pulmonary Drug Delivery Systems Sales Price by Type (2027-2032) & (US$/Unit) Table 235. SAMEA Pulmonary Drug Delivery Systems Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Pulmonary Drug Delivery Systems Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Pulmonary Drug Delivery Systems Sales by Application (2021-2026) & (M Units) Table 238. SAMEA Pulmonary Drug Delivery Systems Sales by Application (2027-2032) & (M Units) Table 239. SAMEA Pulmonary Drug Delivery Systems Sales Price by Application (2021-2026) & (US$/Unit) Table 240. SAMEA Pulmonary Drug Delivery Systems Sales Price by Application (2027-2032) & (US$/Unit) Table 241. SAMEA Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 245. SAMEA Pulmonary Drug Delivery Systems Sales by Country (2021-2026) & (M Units) Table 246. SAMEA Pulmonary Drug Delivery Systems Sales by Country (2027-2032) & (M Units) Table 247. SAMEA Pulmonary Drug Delivery Systems Sales Price by Country (2021-2026) & (US$/Unit) Table 248. SAMEA Pulmonary Drug Delivery Systems Sales Price by Country (2027-2032) & (US$/Unit) Table 249. Brazil Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 250. Argentina Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 251. Chile Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 252. Colombia Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 253. Peru Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 255. Israel Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 256. UAE Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 257. Turkey Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 258. Iran Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 259. Egypt Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Pulmonary Drug Delivery Systems Distributors List Table 263. Pulmonary Drug Delivery Systems Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Pulmonary Drug Delivery Systems Image Figure 2. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Drug Delivery Systems Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nebulizers Image Figure 5. Dry Powder Inhaler (DPI) Image Figure 6. Metered Dose Inhaler (MDI) Image Figure 7. Global Pulmonary Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pulmonary Drug Delivery Systems Market Size Share 2021 VS 2025 VS 2032 Figure 9. COPD Image Figure 10. Asthma Image Figure 11. Others Image Figure 12. Global Pulmonary Drug Delivery Systems Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pulmonary Drug Delivery Systems Revenue (2021-2032) & (US$ Million) Figure 14. Global Pulmonary Drug Delivery Systems Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2021-2032) Figure 17. Global Pulmonary Drug Delivery Systems Sales (2021-2032) & (M Units) Figure 18. Global Pulmonary Drug Delivery Systems Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 19. Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pulmonary Drug Delivery Systems Sales YoY (2021-2032) & (M Units) Figure 21. Europe Pulmonary Drug Delivery Systems Sales YoY (2021-2032) & (M Units) Figure 22. China Pulmonary Drug Delivery Systems Sales YoY (2021-2032) & (M Units) Figure 23. Asia (Excluding China) Pulmonary Drug Delivery Systems Sales YoY (2021-2032) & (M Units) Figure 24. South America, Middle East and Africa Pulmonary Drug Delivery Systems Sales YoY (2021-2032) & (M Units) Figure 25. Global Pulmonary Drug Delivery Systems Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pulmonary Drug Delivery Systems Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pulmonary Drug Delivery Systems Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2021-2032) Figure 31. Global Pulmonary Drug Delivery Systems Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 32. Global Pulmonary Drug Delivery Systems Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2021-2032) Figure 34. Global Pulmonary Drug Delivery Systems Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2021-2032) Figure 37. Global Pulmonary Drug Delivery Systems Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 38. Global Pulmonary Drug Delivery Systems Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2021-2032) Figure 40. North America Pulmonary Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 41. North America Pulmonary Drug Delivery Systems Sales Share by Type (2021-2032) Figure 42. North America Pulmonary Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 43. North America Pulmonary Drug Delivery Systems Sales Share by Application (2021-2032) Figure 44. North America Pulmonary Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 45. North America Pulmonary Drug Delivery Systems Sales Share by Country (2021-2032) Figure 46. Europe Pulmonary Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 47. Europe Pulmonary Drug Delivery Systems Sales Share by Type (2021-2032) Figure 48. Europe Pulmonary Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 49. Europe Pulmonary Drug Delivery Systems Sales Share by Application (2021-2032) Figure 50. Europe Pulmonary Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 51. Europe Pulmonary Drug Delivery Systems Sales Share by Country (2021-2032) Figure 52. China Pulmonary Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 53. China Pulmonary Drug Delivery Systems Sales Share by Type (2021-2032) Figure 54. China Pulmonary Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 55. China Pulmonary Drug Delivery Systems Sales Share by Application (2021-2032) Figure 56. Asia Pulmonary Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 57. Asia Pulmonary Drug Delivery Systems Sales Share by Type (2021-2032) Figure 58. Asia Pulmonary Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 59. Asia Pulmonary Drug Delivery Systems Sales Share by Application (2021-2032) Figure 60. Asia Pulmonary Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 61. Asia Pulmonary Drug Delivery Systems Sales Share by Country (2021-2032) Figure 62. SAMEA Pulmonary Drug Delivery Systems Revenue Share by Type (2021-2032) Figure 63. SAMEA Pulmonary Drug Delivery Systems Sales Share by Type (2021-2032) Figure 64. SAMEA Pulmonary Drug Delivery Systems Revenue Share by Application (2021-2032) Figure 65. SAMEA Pulmonary Drug Delivery Systems Sales Share by Application (2021-2032) Figure 66. SAMEA Pulmonary Drug Delivery Systems Revenue Share by Country (2021-2032) Figure 67. SAMEA Pulmonary Drug Delivery Systems Sales Share by Country (2021-2032) Figure 68. Pulmonary Drug Delivery Systems Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pulmonary Drug Delivery Systems Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nebulizers
  • Dry Powder Inhaler (DPI)
  • Metered Dose Inhaler (MDI)
Applications
  • COPD
  • Asthma
  • Others
Companies covered
  • 3M
  • GSK
  • AstraZeneca
  • Cipla
  • Chiesi
  • Boehringer Ingelheim
  • Aptar
  • Novartis
  • Philips Respironics
  • Omron Healthcare
  • PARI
  • Skyepharma
  • CareFusion
  • Shanghai Huarui
  • Taian Character
  • Chia Tai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pulmonary Drug Delivery Systems Market by Type
  3. 1.2.1 Global Pulmonary Drug Delivery Systems Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nebulizers
  5. 1.2.3 Dry Powder Inhaler (DPI)
  6. 1.2.4 Metered Dose Inhaler (MDI)
  7. 1.3 Pulmonary Drug Delivery Systems Market by Application
  8. 1.3.1 Global Pulmonary Drug Delivery Systems Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 COPD
  10. 1.3.3 Asthma
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pulmonary Drug Delivery Systems Market Dynamics
  1. 2.1 Pulmonary Drug Delivery Systems Industry Trends
  2. 2.2 Pulmonary Drug Delivery Systems Industry Drivers
  3. 2.3 Pulmonary Drug Delivery Systems Industry Opportunities and Challenges
  4. 2.4 Pulmonary Drug Delivery Systems Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pulmonary Drug Delivery Systems Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pulmonary Drug Delivery Systems Revenue by Region
  3. 3.2.1 Global Pulmonary Drug Delivery Systems Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pulmonary Drug Delivery Systems Revenue by Region (2021-2026)
  5. 3.2.3 Global Pulmonary Drug Delivery Systems Revenue by Region (2027-2032)
  6. 3.2.4 Global Pulmonary Drug Delivery Systems Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pulmonary Drug Delivery Systems Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pulmonary Drug Delivery Systems Sales by Region
  9. 3.4.1 Global Pulmonary Drug Delivery Systems Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pulmonary Drug Delivery Systems Sales by Region (2021-2026)
  11. 3.4.3 Global Pulmonary Drug Delivery Systems Sales by Region (2027-2032)
  12. 3.4.4 Global Pulmonary Drug Delivery Systems Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers
  2. 4.1.1 Global Pulmonary Drug Delivery Systems Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pulmonary Drug Delivery Systems Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pulmonary Drug Delivery Systems Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pulmonary Drug Delivery Systems Sales by Manufacturers
  6. 4.2.1 Global Pulmonary Drug Delivery Systems Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pulmonary Drug Delivery Systems Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pulmonary Drug Delivery Systems Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pulmonary Drug Delivery Systems Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pulmonary Drug Delivery Systems Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pulmonary Drug Delivery Systems Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pulmonary Drug Delivery Systems Manufacturers, Product Type & Application
  13. 4.7 Global Pulmonary Drug Delivery Systems Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pulmonary Drug Delivery Systems Market CR5 and HHI
  16. 4.8.2 2025 Pulmonary Drug Delivery Systems Tier 1, Tier 2, and Tier 3
5 Pulmonary Drug Delivery Systems Market by Type
  1. 5.1 Global Pulmonary Drug Delivery Systems Revenue by Type
  2. 5.1.1 Global Pulmonary Drug Delivery Systems Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pulmonary Drug Delivery Systems Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pulmonary Drug Delivery Systems Sales by Type
  6. 5.2.1 Global Pulmonary Drug Delivery Systems Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Drug Delivery Systems Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pulmonary Drug Delivery Systems Price by Type
6 Pulmonary Drug Delivery Systems Market by Application
  1. 6.1 Global Pulmonary Drug Delivery Systems Revenue by Application
  2. 6.1.1 Global Pulmonary Drug Delivery Systems Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pulmonary Drug Delivery Systems Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pulmonary Drug Delivery Systems Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pulmonary Drug Delivery Systems Sales by Application
  6. 6.2.1 Global Pulmonary Drug Delivery Systems Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pulmonary Drug Delivery Systems Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Pulmonary Drug Delivery Systems Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pulmonary Drug Delivery Systems Price by Application
7 Company Profiles
  1. 7.1 3M
  2. 7.1.1 3M Company Information
  3. 7.1.2 3M Business Overview
  4. 7.1.3 3M Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 3M Pulmonary Drug Delivery Systems Product Portfolio
  6. 7.1.5 3M Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Pulmonary Drug Delivery Systems Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 AstraZeneca
  14. 7.3.1 AstraZeneca Company Information
  15. 7.3.2 AstraZeneca Business Overview
  16. 7.3.3 AstraZeneca Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AstraZeneca Pulmonary Drug Delivery Systems Product Portfolio
  18. 7.3.5 AstraZeneca Recent Developments
  19. 7.4 Cipla
  20. 7.4.1 Cipla Company Information
  21. 7.4.2 Cipla Business Overview
  22. 7.4.3 Cipla Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cipla Pulmonary Drug Delivery Systems Product Portfolio
  24. 7.4.5 Cipla Recent Developments
  25. 7.5 Chiesi
  26. 7.5.1 Chiesi Company Information
  27. 7.5.2 Chiesi Business Overview
  28. 7.5.3 Chiesi Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Chiesi Pulmonary Drug Delivery Systems Product Portfolio
  30. 7.5.5 Chiesi Recent Developments
  31. 7.6 Boehringer Ingelheim
  32. 7.6.1 Boehringer Ingelheim Company Information
  33. 7.6.2 Boehringer Ingelheim Business Overview
  34. 7.6.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Portfolio
  36. 7.6.5 Boehringer Ingelheim Recent Developments
  37. 7.7 Aptar
  38. 7.7.1 Aptar Company Information
  39. 7.7.2 Aptar Business Overview
  40. 7.7.3 Aptar Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Aptar Pulmonary Drug Delivery Systems Product Portfolio
  42. 7.7.5 Aptar Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Pulmonary Drug Delivery Systems Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Philips Respironics
  50. 7.9.1 Philips Respironics Company Information
  51. 7.9.2 Philips Respironics Business Overview
  52. 7.9.3 Philips Respironics Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Philips Respironics Pulmonary Drug Delivery Systems Product Portfolio
  54. 7.9.5 Philips Respironics Recent Developments
  55. 7.10 Omron Healthcare
  56. 7.10.1 Omron Healthcare Company Information
  57. 7.10.2 Omron Healthcare Business Overview
  58. 7.10.3 Omron Healthcare Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Omron Healthcare Pulmonary Drug Delivery Systems Product Portfolio
  60. 7.10.5 Omron Healthcare Recent Developments
  61. 7.11 PARI
  62. 7.11.1 PARI Company Information
  63. 7.11.2 PARI Business Overview
  64. 7.11.3 PARI Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 PARI Pulmonary Drug Delivery Systems Product Portfolio
  66. 7.11.5 PARI Recent Developments
  67. 7.12 Skyepharma
  68. 7.12.1 Skyepharma Company Information
  69. 7.12.2 Skyepharma Business Overview
  70. 7.12.3 Skyepharma Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Skyepharma Pulmonary Drug Delivery Systems Product Portfolio
  72. 7.12.5 Skyepharma Recent Developments
  73. 7.13 CareFusion
  74. 7.13.1 CareFusion Company Information
  75. 7.13.2 CareFusion Business Overview
  76. 7.13.3 CareFusion Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CareFusion Pulmonary Drug Delivery Systems Product Portfolio
  78. 7.13.5 CareFusion Recent Developments
  79. 7.14 Shanghai Huarui
  80. 7.14.1 Shanghai Huarui Company Information
  81. 7.14.2 Shanghai Huarui Business Overview
  82. 7.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Shanghai Huarui Pulmonary Drug Delivery Systems Product Portfolio
  84. 7.14.5 Shanghai Huarui Recent Developments
  85. 7.15 Taian Character
  86. 7.15.1 Taian Character Company Information
  87. 7.15.2 Taian Character Business Overview
  88. 7.15.3 Taian Character Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Taian Character Pulmonary Drug Delivery Systems Product Portfolio
  90. 7.15.5 Taian Character Recent Developments
  91. 7.16 Chia Tai Tianqing
  92. 7.16.1 Chia Tai Tianqing Company Information
  93. 7.16.2 Chia Tai Tianqing Business Overview
  94. 7.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Portfolio
  96. 7.16.5 Chia Tai Tianqing Recent Developments
8 North America
  1. 8.1 North America Pulmonary Drug Delivery Systems Market Size by Type
  2. 8.1.1 North America Pulmonary Drug Delivery Systems Revenue by Type (2021-2032)
  3. 8.1.2 North America Pulmonary Drug Delivery Systems Sales by Type (2021-2032)
  4. 8.1.3 North America Pulmonary Drug Delivery Systems Price by Type (2021-2032)
  5. 8.2 North America Pulmonary Drug Delivery Systems Market Size by Application
  6. 8.2.1 North America Pulmonary Drug Delivery Systems Revenue by Application (2021-2032)
  7. 8.2.2 North America Pulmonary Drug Delivery Systems Sales by Application (2021-2032)
  8. 8.2.3 North America Pulmonary Drug Delivery Systems Price by Application (2021-2032)
  9. 8.3 North America Pulmonary Drug Delivery Systems Market Size by Country
  10. 8.3.1 North America Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pulmonary Drug Delivery Systems Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pulmonary Drug Delivery Systems Market Size by Type
  2. 9.1.1 Europe Pulmonary Drug Delivery Systems Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pulmonary Drug Delivery Systems Sales by Type (2021-2032)
  4. 9.1.3 Europe Pulmonary Drug Delivery Systems Price by Type (2021-2032)
  5. 9.2 Europe Pulmonary Drug Delivery Systems Market Size by Application
  6. 9.2.1 Europe Pulmonary Drug Delivery Systems Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pulmonary Drug Delivery Systems Sales by Application (2021-2032)
  8. 9.2.3 Europe Pulmonary Drug Delivery Systems Price by Application (2021-2032)
  9. 9.3 Europe Pulmonary Drug Delivery Systems Market Size by Country
  10. 9.3.1 Europe Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pulmonary Drug Delivery Systems Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pulmonary Drug Delivery Systems Market Size by Type
  2. 10.1.1 China Pulmonary Drug Delivery Systems Revenue by Type (2021-2032)
  3. 10.1.2 China Pulmonary Drug Delivery Systems Sales by Type (2021-2032)
  4. 10.1.3 China Pulmonary Drug Delivery Systems Price by Type (2021-2032)
  5. 10.2 China Pulmonary Drug Delivery Systems Market Size by Application
  6. 10.2.1 China Pulmonary Drug Delivery Systems Revenue by Application (2021-2032)
  7. 10.2.2 China Pulmonary Drug Delivery Systems Sales by Application (2021-2032)
  8. 10.2.3 China Pulmonary Drug Delivery Systems Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pulmonary Drug Delivery Systems Market Size by Type
  2. 11.1.1 Asia Pulmonary Drug Delivery Systems Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pulmonary Drug Delivery Systems Sales by Type (2021-2032)
  4. 11.1.3 Asia Pulmonary Drug Delivery Systems Price by Type (2021-2032)
  5. 11.2 Asia Pulmonary Drug Delivery Systems Market Size by Application
  6. 11.2.1 Asia Pulmonary Drug Delivery Systems Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pulmonary Drug Delivery Systems Sales by Application (2021-2032)
  8. 11.2.3 Asia Pulmonary Drug Delivery Systems Price by Application (2021-2032)
  9. 11.3 Asia Pulmonary Drug Delivery Systems Market Size by Country
  10. 11.3.1 Asia Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pulmonary Drug Delivery Systems Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pulmonary Drug Delivery Systems Market Size by Type
  2. 12.1.1 SAMEA Pulmonary Drug Delivery Systems Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pulmonary Drug Delivery Systems Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pulmonary Drug Delivery Systems Price by Type (2021-2032)
  5. 12.2 SAMEA Pulmonary Drug Delivery Systems Market Size by Application
  6. 12.2.1 SAMEA Pulmonary Drug Delivery Systems Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pulmonary Drug Delivery Systems Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pulmonary Drug Delivery Systems Price by Application (2021-2032)
  9. 12.3 SAMEA Pulmonary Drug Delivery Systems Market Size by Country
  10. 12.3.1 SAMEA Pulmonary Drug Delivery Systems Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pulmonary Drug Delivery Systems Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pulmonary Drug Delivery Systems Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pulmonary Drug Delivery Systems Value Chain Analysis
  2. 13.1.1 Pulmonary Drug Delivery Systems Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pulmonary Drug Delivery Systems Production Mode & Process
  6. 13.2 Pulmonary Drug Delivery Systems Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pulmonary Drug Delivery Systems Distributors
  9. 13.2.3 Pulmonary Drug Delivery Systems Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst